XML 33 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Share Capital and Share Premium
 12 Months Ended
Jun. 30, 2023
Share Capital and Share Premium [Abstract]  
Share capital and share premium

Note 15. Share capital and share premium

 

As of June 30, 2023, the share capital stock and share premium amounts to $ 66,996,982.

 

Reconciliation of share capital and share premium

 

   Number
of
shares		   Shares
issued
amount		   Shares
to be
issued
amount		   Share
Premium		 
Opening Balance as of August, 2020   
-
    
-
    
-
    
-
 
Issue of share capital   29,140,000    291,400    
-
    4,308,600 
Balance as of December, 2020   29,140,000    291,400    
-
    4,308,600 
Issue of share capital   1,860,000    18,600    
-
    2,981,400 
Balance as of June 30, 2021   31,000,000    310,000    
-
    7,290,000 
Issue of share capital   
-
    
-
    
-
    
-
 
Balance as of  June 30, 2022   31,000,000    310,000    
-
    7,290,000 
Issue of share capital (Moolec Science shares)   1,500,000    15,000    
-
    8,105,000 
Issue of share capital (SAFE shares)    262, 260    2,623    
-
    3,170,723 
Issue of share capital (LightJump shares)   3,363,810    33,639    
-
    39,610,630 
Issue of share capital (Backstop shares)   1,201,656    12,017    
-
    7,999,023 
Issue of share capital   3,519    36    
-
    10,647 
From business acquisition   
-
    
-
    641    217,275 
Equity settled share based payment   232,523    2,326    2,427    593,684 
Balance as of June 30, 2023   37,563,768    375,641    3,068    66,996,982 

 

Share Purchase Agreement

 

On April 14, the Company entered into a Share Purchase Agreement with Nomura Securities International, Inc (“Nomura”). The Agreement provides for a committed equity financing facility under which the Company has the option, but not the obligation, to sell up to the equivalent of $50 million in aggregate gross purchase price of its ordinary shares to Nomura over a 36-month period, subject to the terms of the Agreement. The Company intends to use the proceeds from any future sales of securities under the financing facility, if it is utilized, for general corporate purposes.

 

Sales of ordinary shares to Nomura, and the timing of any such sales, will be determined by the Company from time to time in its sole discretion and will depend on a variety of factors, including, among other things, market conditions, the trading price of the ordinary shares and determinations by the Company regarding the use of proceeds from any sale.

 

As of June 30, 2023 only 3,600 shares (equivalent to $10,647) were issued under the Share Purchase Agreement.